<SEC-DOCUMENT>0001437749-23-028325.txt : 20231017
<SEC-HEADER>0001437749-23-028325.hdr.sgml : 20231017
<ACCEPTANCE-DATETIME>20231017090010
ACCESSION NUMBER:		0001437749-23-028325
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20231017
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20231017
DATE AS OF CHANGE:		20231017

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Moleculin Biotech, Inc.
		CENTRAL INDEX KEY:			0001659617
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				474671997
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37758
		FILM NUMBER:		231328564

	BUSINESS ADDRESS:	
		STREET 1:		5300 MEMORIAL DRIVE
		STREET 2:		SUITE 950
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77007
		BUSINESS PHONE:		713-300-5160

	MAIL ADDRESS:	
		STREET 1:		5300 MEMORIAL DRIVE
		STREET 2:		SUITE 950
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77007
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mbrx20231016_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:mbrx="http://www.mbrx.com/20231017"><head>
	<title>mbrx20231016_8k.htm</title>
	<!-- Generated by ThunderDome Portal - 10/17/2023 12:50:34 AM -->
<meta http-equiv="Content-Type" content="text/html" /></head>
<body style="cursor: auto; padding: 0in 0.1in; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20238K" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20238K" name="dei:EntityCentralIndexKey">0001659617</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="mbrx-20231017.xsd" xlink:type="simple" />
</ix:references>
<ix:resources>
<xbrli:context id="d20238K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001659617</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-10-17</xbrli:startDate>
<xbrli:endDate>2023-10-17</xbrli:endDate>
</xbrli:period>
</xbrli:context>



</ix:resources>
</ix:header>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>WASHINGTON, D.C. 20549</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM <ix:nonNumeric contextRef="d20238K" name="dei:DocumentType"><b>8-K</b></ix:nonNumeric></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CURRENT REPORT</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): <ix:nonNumeric contextRef="d20238K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate"><b>October 17, 2023</b></ix:nonNumeric></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="text-align:center;font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><img alt="mbrx20231016_8kimg001.jpg" src="mbrx20231016_8kimg001.jpg" style="width:218;height:93;" /></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityRegistrantName"><b>MOLECULIN BIOTECH, INC.</b></ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Exact Name of Registrant as Specified in its Charter)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:7.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><b>Delaware</b></ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:7.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityFileNumber"><b>001-37758</b></ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:7.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityTaxIdentificationNumber"><b>47-4671997</b></ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:7.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(State or Other Jurisdiction of</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Incorporation or Organization)</div>
			</td>
			<td style="vertical-align:top;width:7.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Commission File No.)</div>
			</td>
			<td style="vertical-align:top;width:7.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(I.R.S. Employer Identification</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">No.)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressAddressLine1"><b>5300 Memorial Drive, Suite 950</b></ix:nonNumeric><b>, <ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressCityOrTown"><b>Houston</b></ix:nonNumeric>, <ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressStateOrProvince"><b>TX</b></ix:nonNumeric> <ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressPostalZipCode"><b>77007</b></ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Address of principal executive offices and zip code)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(<ix:nonNumeric contextRef="d20238K" name="dei:CityAreaCode"><b>713</b></ix:nonNumeric>) <ix:nonNumeric contextRef="d20238K" name="dei:LocalPhoneNumber"><b>300-5160</b></ix:nonNumeric></b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Registrant&#8217;s telephone number, including area code)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Former name or former address, if changed from last report)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see </i>General Instruction A.2. below):</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:3.3%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:3.3%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:3.3%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14(c))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; Emerging growth company&#xa0;<ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#xa0;&#9744;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: bottom; width: 0.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Title of each class</b></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-top: 1px solid black; border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Trading Symbol (s)</b></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.8%; border-top: 1px solid black; border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Name of each exchange on which registered</b></div>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.8%; border-left: 1px solid black; border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:Security12bTitle">Common Stock</ix:nonNumeric>, par value $.001 per share</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:TradingSymbol">MBRX</ix:nonNumeric></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.8%; border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">The <ix:nonNumeric contextRef="d20238K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric> Stock Market LLC</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#xa0;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 54pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Item 7.01 </b></div>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Regulation FD Disclosure</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">On October 17, 2023, Moleculin Biotech, Inc. (the &#8220;Company&#8221;), held a virtual investor call with the Company&#8217;s Chairman and Chief Executive Officer, Walter Klemp, discussing the first patient in the Phase 2 study for AML.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">A copy of the script is attached to this report as Exhibit 99.1 and is incorporated by reference herein.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be &#8220;filed&#8221; for the purpose of the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;), nor shall it be incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended (&#8220;Securities Act&#8221;), unless specifically identified therein as being incorporated by reference.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 54pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Item 9.01 </b></div>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Financial Statements and Exhibits.</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 18pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(d)</div>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Exhibits.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 54pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Exhibit</b></div>

			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>No.</b></div>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Description</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 54pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">99.1</div>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><a href="ex_581636.htm" style="-sec-extract:exhibit;">Script of investor call<span style="text-decoration: underline;">&#xa0;dated October 17, 2023</span></a></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="vertical-align: top; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 54pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">104</div>
			</td>
			<td style="width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Cover page Interactive Data File (formatted as Inline XBRL document)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b><span style="text-decoration: underline;">SIGNATURE</span></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:54pt;">Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:23.2%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:1.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>MOLECULIN BIOTECH, INC.</b>&#xa0;</div>
			</td>
			<td style="vertical-align:top;width:5.6%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:23.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:1.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:15.7%;">&#xa0;</td>
			<td style="vertical-align:top;width:5.6%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:23.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:1.9%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:15.7%;">&#xa0;</td>
			<td style="vertical-align:top;width:5.6%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:23.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:1.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date:</div>
			</td>
			<td style="vertical-align:bottom;width:15.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">October 17, 2023</div>
			</td>
			<td style="vertical-align:top;width:5.6%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:23.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:1.9%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:15.7%;">&#xa0;</td>
			<td style="vertical-align:top;width:5.6%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:23.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:1.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</div>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:15.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/&#xa0;Jonathan P. Foster</div>
			</td>
			<td style="vertical-align:top;width:5.6%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:23.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:1.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:15.7%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Jonathan P. Foster</div>
			</td>
			<td style="vertical-align:top;width:5.6%;">&#xa0;</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex_581636.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_581636.htm</title>
	<!-- Generated by ThunderDome Portal - 10/17/2023 12:52:25 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 99.1</b></font></p>

<p style="margin: 0px 0pt; text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">
			<div><img alt="virtual_investorlogo.jpg" src="virtual_investorlogo.jpg"></div>
			</td>
			<td style="width: 50%; text-align: right;">
			<div><img alt="investor_relationslogo.jpg" src="investor_relationslogo.jpg"></div>
			</td>
		</tr>

</table>

<p style="margin: 0px 0pt; text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>Planned Video Script </u></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Virtual Investor: Moleculin Doses First Patient in Phase 2 Study for AML </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Participants: </b></p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Jenene Thomas, CEO of JTC IR - Moderator</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Wally Klemp, Chairman and Chief Executive Officer of Moleculin Biotech</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;margin:0pt;"><b>Moleculin Bio (Nasdaq: MBRX) </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Jenene Introduction: </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Hello and thank you for joining us today for another Virtual Investor &#8211;&nbsp;What This Means Segment. My name is Jenene Thomas, CEO of JTC IR, and I will be the moderator for the event.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">I am pleased to be joined by Walter Klemp, Chairman and Chief Executive of Moleculin Bio.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Before we get started, I just want to inform our audience that Moleculin Bio is listed on the Nasdaq and trades under the ticker M B R X. During today&#8217;s discussion, the Company will be making forward-looking statements and actual results could differ materially from these forward-looking statements. Some of the factors that could cause actual results to differ materially from these contemplated by such forward-looking statements are discussed in the periodic reports Moleculin files with the Securities and Exchange Commission. These documents are available in the Investors section of the Company's website and on the Securities and Exchange Commission's website. We encourage you to review these documents carefully.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Moderated questions </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Jenene Question:</b>&nbsp;Wally, last time we spoke you announced publicly that you are gearing up for a year of data and it seems the first of many milestones has been achieved. Focusing on your AML program for this segment can you discuss the status of your ongoing clinical study of annamycin for AML?</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">a)</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Wally Response:</b>&nbsp;Well, as a quick review, the AML space is dominated by combination therapies &#8211;&nbsp;that&#8217;s true for chemotherapy drugs such as anthracyclines and for other drug therapies &#8211;&nbsp;like venetoclax. In fact, it&#8217;s very difficult to get investigators to treat patients with a single agent or monotherapy, especially when those patients have a reasonable chance of achieving lasting remission. Unfortunately, the regulatory authorities require that you demonstrate safety and efficacy as a monotherapy before being allowed to go into combination with other drugs.</p>
			</td>
		</tr>

</table>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">That&#8217;s&nbsp;what the last 5 plus years has been all about for us. We had to validate in monotherapy human trials the safety, including the absence of cardiotoxicity, and efficacy that had been shown previously in animal studies. As you know, all currently prescribed anthracyclines are significantly cardiotoxic, so a truly noncardiotoxic anthracycline would be considered a major breakthrough.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">
			<div><img alt="virtual_investorlogo.jpg" src="virtual_investorlogo.jpg"></div>
			</td>
			<td style="width: 50%; text-align: right;">
			<div><img alt="investor_relationslogo.jpg" src="investor_relationslogo.jpg"></div>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 18pt; text-align: justify;">It&#8217;s&nbsp;been a long hard road to get here, but we are finally at what I call the &#8220;starting line&#8221; with Annamycin in AML. Specifically, we are finally in a Phase 2 combination trial where every patient adds to the body of evidence that supports an approval pathway for our drug.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 18pt;">That said, what we&#8217;ve seen along the way is pretty impressive.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 18pt;">We&#8217;ve now treated 36 patients across three AML trials in the US and Europe. The patients in our most recent trials have mostly been in excess of 60 years of age and heavily pre-treated with other therapies. As we have previously reported, we saw 3 CRi&#8217;s in the 5 patients treated in the last cohort of our monotherapy trial. And now we&#8217;ve seen 2 CR&#8217;s (and I should add, durable CR&#8217;s) from the first 6 patients in the lead-in cohorts of our combination trial. So, our complete response rate has ranged from 33% to 60%. Importantly, though, the patients we are now treating are in the phase 2 portion of the combination trial. And, this is where our efficacy data really starts to matter and where we think it will truly shine.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 18pt;">So, I am looking forward to beginning to report preliminary Phase 2 data when we report our Q3 earnings in the first part of November.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 18pt;">One thing I have to stress, though, is why we refer to Annamycin as a &#8220;next generation anthracycline or a next generation chemotherapy&#8221;. We have shown Annamycin to have effectively no cardiotoxicity in preclinical studies. Now, we&#8217;ve treated 66 patients across two indications (AML and Soft Tissue Sarcomas) and have yet to see a single instance of cardiotoxicity. This is critically important as the <u>first</u> black box warning for all currently prescribed anthracyclines like doxorubicin is literally &#8220;cardiomyopathy&#8221; or heart damage. So, we believe - not seeing any cardiotoxicity in the first 66 patients treated, most of whom we&#8217;ve taken well over the FDA&#8217;s lifetime maximum limit for anthracycline therapy - is remarkable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">2)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Jenene Question: </b>You recently announced the first patients dosed in the Phase 2 portion of your study. Can you discuss what this means for the AML program?</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">a)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Wally Response: </b>We had several expectations once we were able to begin recruiting Phase 2 patients. One was that we would start seeing healthier patients who would have a better chance of responding to Annamycin than the heavily pretreated patients we&#8217;ve seen to date. We also expected the pace of recruitment to accelerate since the combination is positioned to help an important segment of the AML population that is currently under served. Both of those things are playing the way we hoped. And I hope to be announcing significant additional recruitment in this trial come November.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Now, the reason this is so important is that the Phase 2 data we expect to be announcing should form the basis for positioning Annamycin for an approval pathway and attracting the kind of partnering activities that can lead to exit opportunities for our investors.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Clearly, when you look at the pharma transactions that are getting done today, they are largely being driven by Phase 2 and Phase 3 data. That&#8217;s the kind of data we can now finally start delivering.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">
			<div><img alt="virtual_investorlogo.jpg" src="virtual_investorlogo.jpg"></div>
			</td>
			<td style="width: 50%; text-align: right;">
			<div><img alt="investor_relationslogo.jpg" src="investor_relationslogo.jpg"></div>
			</td>
		</tr>

</table>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">3)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Jenene Question: </b>What are the next steps for your program and what this means for your overall development strategy for annamycin in AML?</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">a)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Wally Response:</b>&nbsp;Based on the patients we now have in screening, we expect that the pace of recruitment will be increasing. Our priority is to fill out this Phase2, which we now think we can do within a matter of months. That should put us in a position to meet with the FDA and the EMA early next year to negotiate the structure of a pivotal approval trial. In fact, we are already in discussions with our investigators about what that trial design will be.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">4)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Jenene Question: </b>What should investor expectations be for Annamycin in AML, both broadly and for the remainder of the year for Moleculin?</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">a)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Wally Response:</b>&nbsp;Broadly speaking, we think Annamycin is well positioned to become the next Venetoclax in AML and, frankly, I think that&#8217;s grossly understating our potential. As it relates to the rest of this year, by the time we are announcing third quarter results, we should be able to comment on Phase 2 patient progress - recruitment and efficacy - and we expect by year end, we should be in a position to give a pretty good efficacy readout on a significant number of patients.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">But it&#8217;s really important for investors to focus on and understand this&#8230;we have already shown a level of patient response that is greater than the CR rates or efficacy shown in some recent approvals, including for example Venetoclax&#8230;and that drug is already generating a half a billion dollars a year in revenue. All we need to do now is continue to deliver similar results in Phase 2, and that should drive licensing opportunities and other support for pivotal approval trials.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Bottom line: I think investors will have an opportunity to get a pretty good read on our Phase 2 progress yet this year.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Jenene Closing: </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">With that, this concludes the Virtual Investor What this Means segment with Moleculin. I would like to thank Wally Klemp, Chairman and CEO of Moleculin for joining us today.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">I would also like to thank our viewers for your time and attention. As a reminder, you can access the webcast replay from today&#8217;s event at: <u>www.virtualinvestorco.com</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>https://www.virtualinvestorco.com/whatthismeans</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;margin:0pt;">Video will be available approx. 60 days</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>mbrx-20231017.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 10/17/2023 12:50:40 AM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:mbrx="http://www.mbrx.com/20231017" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.mbrx.com/20231017">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mbrx-20231017_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mbrx-20231017_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mbrx-20231017_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.mbrx.com/20231017/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="mbrx_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>mbrx-20231017_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 10/17/2023 12:50:40 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.mbrx.com/20231017/role/statement-document-and-entity-information" xlink:href="mbrx-20231017.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.mbrx.com/20231017/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>mbrx-20231017_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 10/17/2023 12:50:40 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>mbrx-20231017_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 10/17/2023 12:50:40 AM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.mbrx.com/20231017/role/statement-document-and-entity-information" xlink:href="mbrx-20231017.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.mbrx.com/20231017/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>investor_relationslogo.jpg
<TEXT>
begin 644 investor_relationslogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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M+<'1]S%<6RKYOF-:/Q5,ERW,:^693EW,K2C3EG&79MF..H/FI8F=#(J[BJF
MIR/-4^,?PID\?O\ "N/XA^$7^(T<9D?P6NN6)\0+MM_M;1?V>)O.^U+:?Z6U
MF!]K6U_TEH1!^\KM9M=T2WN&M;C6=*@ND=4>VFU"TBN%=PI5&A>99%=@RE5*
M@D,I .17X*1>%OV6])_X*'R>)I/C7XX;Q9_PO.9$^'O_  KW4BP^)5[XLDL_
M[,;QN-7-NWAA/$TQ/FG1MSZ2/L<DABW7[_(/[;.JVVC?M\_$G5=0F>&PTSQY
MX-OKR14>5HK6U\.^%YYW6.,-(Y6-&8(BEV(PH)(K\&SGQ^S/AW(LSSG,<@X?
MQ\L+XA5>$,/A\IXJPN(C3RWZIC,50S''UL+2S+ZMB_\ 8JD)X3$0PE5IRG.A
MAO9J-3^I.'?HIY/Q?Q/DW#V4<5<5Y7#&^$V'\0,7BL^X&QV$G6SC^T,NP.*R
MC*L/CJ^3_7,!;,J-6EF&%J8^A%J-.GB<9[5SH_U?45Y!X%^/'PL^(GPO;XS>
M'?%-NGPVCCU>:X\3:Y;W?AVTM(-"NY[+4Y[M-;@L9[:&WN+:5%EEB5)L*T!D
M$B%OD*[_ ."J7[(UKXB;0AXA\87-FEPUN_BBV\(7;>'U*.4:4++<P^()( 02
M'BT&0NN&C5U()_;\SX^X)R7#Y9B\UXKR# 8;.:-/$Y37Q.:82G2S##55&4,5
MA)NK:MA)1G"7UJ#>'2G%NHE)7_FC)?"OQ)XCQ><X#(N!.*LTQO#V(JX3/,+@
M\DQ]6ME.-HRG"K@<?!4+X?'1E3G'ZE4MBFX34:+<96_1RN/\?>!O#WQ*\(:[
MX)\46SW&C:]9FVF:"0V]]8W$;I<:?JVEW:_O+#6-'OX;;4])U"'$UCJ-I;74
M1#Q"KGA#QAX7\?>'-*\7>#-=TWQ+X:UNW%UI>LZ3<+<V5W#N:-]KK\T<T,J/
M!<VTRQW%K<1RV]S%%/&\:])7TDE@\SP3B_J^.R_,,,XNSAB,+C,'BJ5G:47*
ME6H5Z,]&G*%2G.Z;BSX^,LQR;,8SC];RS-<JQJDKQJX3'8#'X*M=7C)0K8?%
M87$4]8R4:E*K"S2E&QX=\"/&/B#7/#^M^#?'5REU\2?A3KTO@;QG>+$+<>(/
ML]K;ZAX9\;06XP(K;QMX7O-+UUD0"*VU.?5-.C_X\& ]QKYNU9!X0_:C\(ZG
M ?*L?C+\,_$7A;5HD^5+CQ1\+K^U\2^%[J1<?O+F3PUXD\:6QDR&^S:=!&VY
M8X]GTC7E\/5:RPF)R[$U:E?$Y)CJV55*]63J5:]&G2H8O+:U:JW>KB:N4XS+
MZF+JNW/BY5W9+0]OBVAA_KV#S;!T*6&P?$F68?/:.&H05*AAL15K8G 9QAL/
M1BDJ&#P^?Y?FM'+Z*<O9Y?#"Q<I.[/G36?G_ &L/A]YO2'X!_%5K('IYDWC[
MX3+?E1ZB.*P#$8(#*.AP?HNOF_XLM_PC7QD_9W\>R8CT^ZUOQE\(M8N.T*?$
M?1+75_#XE;("17/BSP+HNF(QR&O=2LX0-\JUWOCKXW_"#X8WS:7\0_B1X/\
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MCURV>"UM[JQ:_>^D\'W=S<V\=Z;>"U>*XN7N+ZV,H2>V^W7,7WQ\.?B?X/\
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M_P 3:6C[>3%GY:8?%'[3OB<&#1/A7\/_ (8Q-Q_;'Q$\=R^,K^!&&/,B\)^
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+3E)E%%%>@>4?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>mbrx20231016_8kimg001.jpg
<TEXT>
begin 644 mbrx20231016_8kimg001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" != -H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MI,T +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %)2TE "T44E "5YQJ,'B+P_JLNIM=2SV)O!(\S3DK' W#*T.,?+_>!]Z9
M<^.]>9-5U2RTRS;1]*F>&=))R)I=O5E[#Z'K74ZU;OXE\&RBSE:!KNV#(2<=
M1G:3Z'H:ZH4Y46N9*ST9=&4>=7V+UUJ\<6F/>6JB\"@-MA8$D?\ ZJM6=Y!?
M6PG@D5T/!P<X/<5Y[H[SV^I6SZ?H4^GJELWVQ&4")]H^7:1P3GOZ5O:+JL]O
M91RW=C;PQW;^9']E'&2>0W^UWSWQ6%5*F['14P_+'3?^NAUU+2 Y%%0<@M%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2TE !144T@A@>
M5@2J*6( R>!7E$?Q \11VMKXCN?L3:'<WAB%G$N;A4)('?EO:M:.'G6^'^O(
MF4E'<ZR_^'/A_4-2>]EBGC$S;[BWAF9(KAO5U'6J&O6QU#Q=IOAHW4MII7V%
MI6@@;9YFU@ I/7&.U4+GQ??>+]>L=&\/7-SI*E'FN+BY@VNP' 55;KUIEGIS
MZQK^H>'O$%P]YJ-@JW%IJ<(V2(C?PDKT(/;O7:J=6"O5EJEMU72_;]32@X\U
MU]YN:5"VA>)DT2*[DFTZ:W>6.*8[C$00-H/7'/0U*-&6V\006,=TZZ>$:X2V
M." W((!Z[><XJ ^ [:&T>YDO[R;5%&\7K2$.I'0 = /:H=+TA[G0!K<M_.^J
M,AD$Y;A<?PA>FWCI7FXCWM5J>CS0:YXR\GIU[_UJ;MSK7]F:$+K[+(RQOY6T
MOS@' )/X4N@>)8]<,RB%H6B .&8'(K/U.PD@\'7:RSM-N3S06'()Y/ZURUM<
MMH=\[C(6>TRN/5NGZUXU?%5:%2-_AMJ:4,+2KTI)?'?0Z23Q]"ER\0L795?:
M&WCGG&:W]5URUTFT6:<G<X^1!U:O+9+8Q6EE.WWIF9OP!%;/C1W;5+=&.$6W
M7;^/6N>&85O9SE+=6M\SIJ9=0=2G&&SO?Y&H/B"-_.GOL]0XS72V.M6NHZ<]
MY;DML!+(>""!T-5+W3[)?"SQB*,(L&5..AQUKD_!KN/[109V&WR?KS6ZQ%>C
M4C&;YN9?<<[H8>M2E.G'E<7WW.HT+Q4NMWCVXM7BVIOW%@:WYY/)@>7&=BDX
M]<5YWX!_Y#,O_7#^M>@7I_T&X_ZYM_*NK!8B56ASR>NIS8[#PI8CV<%IH<B/
MB$A/&FRGZ.*NZ7XP74M1CM/L,L7F9^<MD# KBM!;4$OF.FPI+-L.5< \9]Z[
M;19->>_QJ-I%'"$)W*H!SV[UPX7%UZK3DW:_;]3NQF$H44U&*V[Z_<2:WXNM
M=)N#;)&T\P^\JG 7ZFJ5EX^MY9UCNK1X%8XW[L@?6N=TB-+KQB%N0'#3N2&[
MD9Q7;:KINARS0MJ"PHQRJ;FVAO;WK2E7Q-9RG&223M9F5:AAJ'+3E%MM7NO\
MAFN^)8]%,&;=IQ*"058#@5?34E?1O[1,9"F+S-F>>F<9KC_':1H-/6''EK&P
M7'3'%;\##_A!A_UZ_P!*VAB:CK3@WHEH93PU-4*<TM9.S$T/Q0FM/<*+9X?*
M3<<L#FFZ-XM75]1-H+1XCM+;BP/2N>\"_P"LO_\ KB/ZU!X*_P"1D/\ US?^
M=<]+&57[.[^)NYTU,#1BZME\*5CTMCM4GL!FN;TOQ;'J6L#3Q:/'G=\Y<$?+
M[5T<G^J;_=->9^%O^1O7ZRUV8NO.G4A&+T;U./"8>G5I5)26L5H='=^-8++5
MGLY+5]D<FQI0XQ]<5IZSKL6E:?%>+&9DD8!=IQU'6N U>U>\\5W5O%C?))A<
M]SBH)]2G;1O[+G#;H9LIGJ!W4UYSS*I!S4ODST5E=*?LW#RNO)]3T_1]175=
M,BNUC*>9GY2<XP<5?S6#X,_Y%JV^K?S-;V*]FC/GI1E/=H\/$PY*LHQV38O:
MN4A^'GARWUI=5BM&%PLQG5?,/EASWV].]=;3:ZH5)PORNUS%I/<YSQ+X1M/$
MCVDSW-Q9W5HQ,5Q;-M< CD9]*Y8Z;>:!K2^'=$N6-WJ,;75UJ=XWF2A5(7 ]
M3Z9JG?\ C+Q'/'K.LV>H:=:V6D3O#]AD7<]QMZY.<@GMBNDU'1[O68]/\2V%
M]]@U1;,9#C=$RL Q5AZ9[UWI5*45&I)6UT[/S*HRCS% 0>);?4X_#?\ ;"RP
MSQ-*+N1,S*@(#+Z$\]:MP:+?V5TN@1:BS:>\9?<5_>HN>5!]SWJIX=U+3Y-4
MEO;O5_MVJ&%L;%*Q(@Y94['IUJ>"2ZDGL-8DO2UU<$_N8R/+$1SM&/KCFO/Q
M2?4]63DGRZ+3MN^YI?8+B\\*W5M;W!GFD8QJTC8P%.,?D*S]9\*WMW:V)MQ'
MYL,(CE!;'3I79VT;10(C;=^,L57 )[U/WKBG@Z=2-I]CDABZE.?-#O<XC6/"
MUY<V^FQ6BQD6\>U]S8YXK3\1>&_[8@A:)ECN8EP">C#T-=)C%&*/J5*TDUO;
M\ ^NUDXM/X;V^9YT=!\4O;BQ:3_1QQ@R_+C^>*Z+1O#@TG2YX]_F7,R$,W;I
MP!7148[_ *5-+ 4H2YM6_,JKCZM2/)HEOHMSS:V\)^(+1M]LZ1L1@LDN#C\J
MV=(TGQ!#<3&_N2\+0LH4R;OF/2NQ[4G/>E3RZE3=XM_>54S&K45I)?=J>;VO
MA3Q#92&2V:..0C!82=ORK9TK3_$\6HPO>78:W!_>+NSD8^E=AU-&**>7TZ;O
M%O[Q5<PJ54U**^XXC6_"5VVHM?Z5(H=FWE<X(;U!JG_PC&NZO<QMJDH$:\%F
M8$@>P%>A8HZ4I9=2<G+77IT'',JT8J.EUHG;4Y[7/#2:EI<5O;L$D@&(BW3&
M.AKFO[ \3K;&Q5C]F/&T2C;C^>*]&H_E55L!2J2YM4]M":./JTH\FC6^J.>\
M/>'CI%A.LCJ]S,,,5Z#C@5R\7A+7[6<RVYCC<Y&Y9,''Y5Z5BDQBB>7TIQC'
M5<NPZ>85H2E+1\V]SC]%TOQ#;ZD'OKHM!L8%3)NY[<5#H7AG4;#Q#]LG$0A!
M?D/D\]*[?%&*%@::Y=6[.^XOKU3WDDES*ST.+/AN_P#^$O.HXC^S^=OSNYQC
MTI?$WA.6_O%N[ ()'XD5C@'WKL\48%$L!2E!Q>S=PCF%>,XS3U2M\C(\.:?/
MIVC16UP%$JDYVG(Y-:^*6DXKKIP4(**Z')4ESR<Y;L=24M%62<Y=^"_#MYJJ
MZG<:5;O= Y+%.&/JPZ$^YJIXWN8!X9N[!+P174R".&*,@NY)X4+UP>GTKK*X
MQ/ :G69;ZZO3<(]W]K4-$!*&'W5,F<[1Z 5O3G=IU)/38NERQDI,@@L)K>.W
MU+7K>UL[:P@VQ01'=@L-IR?IQCWK=\.V$%M9R/'IL=D))"50-NRN>#[?3M6S
M)%'*FR1%=?1AD5( -N!64Y<[NS2I7E-6%I:**DP"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "DI:2@!:*2B@!:2BB@ I:2B@!:*2B@!:*
M2B@!:*2B@!:*2B@!:*2B@!:*2B@!:*2B@!:*2B@!:*2B@!:*2B@!:2BB@#__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>virtual_investorlogo.jpg
<TEXT>
begin 644 virtual_investorlogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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M_:]^!7A_P-X7^(>III.C^,_!6HO=66F7+S6ULTE\8O$?B_3[M;26YBFO[/\
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M8^,/%-MK'A1]+T*ZU*XO]+@LH;Z<")[B74;-(P=S7$8&:_=C_@KQ^PC\0_\
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M4[/7M&>3?=^'/$MGHOQ9&KZ'=Y"LS6TLB2VEQL5;W3[BSO$51/L7T;X\1?\
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M34KR"6]CTNZOM"U&QU#^Q]2M([_23ICV%]!':WFG,9)9+;E_^"NG_(D? /\
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M&#"&W!?S;-N!>,N)LSGQ1++LRX7K<2>)W!&91P6#Q&55LZX=X?X9X?SG*O\
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1/%576R^5##U*5*OA:TZW_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140208239895088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 17, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">MOLECULIN BIOTECH, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Oct. 17,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">001-37758<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">47-4671997<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">5300 Memorial Drive, Suite 950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Houston<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">77007<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">300-5160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MBRX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0001659617<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>mbrx20231016_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mbrx-20231017.xsd" xlink:type="simple"/>
    <context id="d20238K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001659617</identifier>
        </entity>
        <period>
            <startDate>2023-10-17</startDate>
            <endDate>2023-10-17</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20238K">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20238K">0001659617</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20238K">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20238K">2023-10-17</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20238K">MOLECULIN BIOTECH, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20238K">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20238K">001-37758</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20238K">47-4671997</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20238K">5300 Memorial Drive, Suite 950</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20238K">Houston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20238K">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20238K">77007</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20238K">713</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20238K">300-5160</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20238K">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20238K">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20238K">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20238K">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="d20238K">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle contextRef="d20238K">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20238K">MBRX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20238K">NASDAQ</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    (  1(45<'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    "  $2%%7I=?O<NT    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M2L0P$(=?17)O)VG!A=#-1?&D(+B@> O)[&ZP^4,RTN[;V];=+J(/X#$SOWSS
M#4QGDC0QXW.."3,Y+#>C[T.1)FW9D2A)@&*.Z'6IIT28FON8O:;IF0^0M/G0
M!X2&\UOP2-IJTC #J[02F>JLD2:CIIC/>&M6?/K,_0*S!K!'CX$*B%H 4_/$
M=!K[#JZ &4:8??DNH%V)2_5/[-(!=DZ.Q:VI81CJH5URTPX"WIX>7Y9U*Q<*
MZ6!P^E6<I%/"+;M,?FWO[G</3#6\:2O!*['9B59R+OGF?7;]X7<5]M&ZO?O'
MQA=!U<&ONU!?4$L#!!0    (  1(45>97)PC$ 8  )PG   3    >&PO=&AE
M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?
MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@
MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?<D3$L/<@HL(2W@4R]9<
MX%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A T%116F]?(+3E'S/X%<M4C66C 1-7
M02:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1
MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP
M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?=
MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP
M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%,
M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I
MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88<G;CL3<CH<9T)\S_;VD:4E
M,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ
MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A
M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<HY=8%0&7&-\TJC4LQ=9XE<#QK9P\
M'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^G-- \)0O)/I*D8]ILR.G=";-Z#,:
MP4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:
M<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^8,CLS9%USM:1#A&27C="/F+.BY 1
MOQZ&.$J:[:)Q6 3]GE[#2<'H@LMF_;A^AM4S;"R.]T?4%TKD#R:G/^DR- >C
MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_
M+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$^ZXQVM<T+BAC5W+-R,=4KY,IV#F?
MP.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE"<M4TV4WBA*>
M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT
ML<QP3A[+##MG/)(=MG>@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3
M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'
M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\
M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^
M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON<K2<15.+]%,[82EQB\X^;'
M<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)+%N(61+B35WMU>>;G*YZ(G;ZEW?!
M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4<!A87,N10[I*0
M!A,!S93)1/ "@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E$A2*L P%(1=R
MX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS<D/85"7SKMHF"X7;XE3-NQJ^)F!+
MPWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83
M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'
M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
M!$A15]N30AA.!   I!   !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6R5
MF&MOXC@4AO^*E95&NU+;7+BD= &)4CI%TPM3F)W5KO:#20Q836S6=DKY]WL<
M(&$UX83YTESP>?/$/N<]<;L;J=[TBC%#/M)$Z)ZS,F9]X[HZ6K&4ZBNY9@)^
M64B54@.7:NGJM6(TSH/2Q T\K^VFE NGW\WO352_*S.3<,$FBN@L3:G:WK)$
M;GJ.[QQNO/+ERM@;;K^[IDLV9>;;>J+@RBU48IXRH;D41+%%SQGX-[=!TP;D
M(_[@;*./SHE]E;F4;_9B'/<<SQ*QA$7&2E XO+,A2Q*K!!S_[D6=XIDV\/C\
MH'Z?OSR\S)QJ-I3)=QZ;5<^Y=DC,%C1+S*O</+#]"[6L7B03G?\EF]W89LLA
M4::-3/?!0)!RL3O2C_U$' 4T_!,!P3X@R+EW#\HI[ZBA_:Z2&Z+L:%"S)_FK
MYM$ QX5=E:E1\"N'.-._DU$&DVS(0,1D) PW6S(6N]6&6>NZ!AYBA[K17O!V
M)QB<$'R)S!7QPPL2>$'C_^$NL!6 00$8Y'J-.L C*O+W(XPB8\-2_4\5XDZR
M62UI$_U&KVG$>@YDLF;JG3G]3[_X;>]W!+A1 #<P]?YN$B_(*UMR;10%]&>:
MLBI,7.CIY7$T_/8X?B:WXY?9:/AP0<;/PRL$L5D@-E'EPYQ>D-EV74F&QU]?
M?D$H6@5%ZTR*"5-<VO2+"21Q)1 N521=7=:U"[;V68LX%I%4:ZGRM+L@4P-X
M1"HRE)DP:@O'N!(75[\;(8AA@1B>A7C/$T:>LW3.5!4)+N)Y_F4C#%O7"-!U
M 71]%M",?I!Q# O+%SS:U>MI/%RR&5XVVZ'?Z80(7Z?@ZYS%-XACJ'I=G)#<
M3%Y$Y4+BDJV&YY$GEDK%:4+N%#082)*,0Y)T6A["['NE/WL_1SVT%@TI.).;
M:GO&]1ZD;2H"8SOJ'?[/L17U,5'RG8NH<DIK1&=_8FQEV_!1D_^1;2*U@47Z
MBZ]/5FV-9!AZ'I:(?MDB?-S:\S4<P%?4:11<(/0QE_/+1N#C3OXH(YB3R4H*
MS$-J1* (+EO0/3&BLBGXN)5_5]P8)F!BTC03>P/1E52XT((FFF%(92_P<;N>
MRH1'W'"Q)$^0W[;6*WEPE5J>TOA]W+0GBEU&,#T,"BS_-)HQ$3-%7A:+$^N'
MZ]62E1W Q_WZ![*QUAF0U0+BLK6 90OPS^L!HY2II5W0SR!A5C;;UE1L*]EP
MQ3JVH'3Z '?F&3?0R>6"^,&O\]_(E$49U$(E4XV2K1WHNE,CHS<,K33ZH,:3
M%8WM;$VWZ5Q6)G^-P-/M*V;KP=%N /?@PZR0T4>THF+)3GY<UP@]#Z9W@Z\8
M4^GF 6[& TCU.$_W^X0N*UEP@=H<*OT\P*WXD-]#H%'@[&.HNP_RA55G$:[E
MP<=AN]5I^Y4]SSW:<]K]^Q.U!:5)PA:@YEV%X,YJMR7>71BYSK>A<VE@4YN?
MKA@%6[ #X/>%E.9P87>VQ3\F^O\!4$L#!!0    (  1(45>?H!OPL0(  .(,
M   -    >&PO<W1Y;&5S+GAM;-U7;6O;,!#^*T(_8&YB:N*1&+9 8;"-0O-A
M7Y58=@1Z\62Y<_KKI[-L)VEU9=V'L<VAR=T]NKM'=R>9KEMWDOSAR+DCO9*Z
MW="C<\W[)&D/1ZY8^\XT7'ND,E8QYU5;)VUC.2M;<%(R6=[<9(EB0M-BK3MU
MIUQ+#J;3;D-O:%*L*Z//EI0&@U_*%">/3&[HEDFQMV)8RY20IV!>@N%@I+'$
M>2I\0Q=@:9\"O @:L!SC**&-!6,2,H3O_;C\&3!IK5>%E#/!)0V&8MTPY[C5
M=UX9%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.<V"3J9B+7D%=*RHC_#K
M3), Z)Q17B@%JXUF X?)8Q1\V .7\@%:^*VZBMU7)/3B4PEM(+#52?2$1C&$
M"0K$OXP68E^$O?VML*01C\9][/QN]*!_[XSC]Y97HA_TOIKS8]$7>'36-/+T
M08I:*Q[V_LL)BS6;_,C16/'DL\&D'+R!6TH>N77B<&GY85FSX[V;IJFO<,[+
M?Y#SGZUSS36W3%Z2]J/_-U?Y+8R3\?1<'-&K SI;"5R$&_H5[E=YYD#VG9!.
MZ%$[BK+D^L4Y]>$=V_L+_"J^7U_RBG72[69P0\_R%UZ*3N7SJGNHR[CJ+'^&
M^VB1S;>PSR5TR7M>;D?5UOM!)%[P6<<'')XC=\,31S"?@,41P+ \& /,)WAA
M>?ZG_:S0_00,X[:*(BO49X7Z!*\8LAT^6)ZX3^Z?^$[S/$VS#*OH=AMEL,7J
MEF7P%X^&<0,/+ ]D>ENM\6[C$_+Z'& ]?6U"L)WBDXCM%*\U(/&Z@4>>Q[N-
MY0$/K O8[$#^>!Z8J;A/FD)7,6[8"<:1/,<0F,7XC&894IT,/O'^8*<D3?,\
MC@ 69Y"F& *G$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0    (  1(
M45>7BKL<P    !,"   +    7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] A
MB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:
MU;@!2+8ECVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]
MVR]/06^ KSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::
M1<G3HAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$
M%     @ !$A15SJJHN=  0  / (   \   !X;"]W;W)K8F]O:RYX;6R-45UK
MPS ,_"O&/V!)RU98:09CW4=A;&4=?7=BI1&UK6"K[=9?/R4AK+"7/<DZB=/=
M>7&BN"^)]NK+NY *W3"W\RQ+50/>I"MJ(<BDIN@-2QMW66HC&)L: /8NF^;Y
M+/,&@[Y;C%SKF%TVQ% Q4A"P [8(I_0[[UIUQ(0E.N3O0O=O!UIY#.CQ#+;0
MN5:IH=,+13Q38.,V523G"CT9!EN(C-4?>-.)_#1EZA$VY8<1(86>Y4)88TS<
M;_3\1C0>09:'[L#TA(XA+@W#<Z1#BV'7T8B+[,)&G\-8AQ#G\3\Q4EUC!4NJ
M#AX"#SE&<)W D!ILDU;!>"CTN*+N@U6/@24DM0H#E>QV3N7TR@ZN6>1>9!CG
M*(.XLH/P4:V%&@/8-SF0!)?DJG547>EYIM<WDUM)Z.#<@V#OX96,'<V/'W?W
M U!+ P04    "  $2%%7)!Z;HJT   #X 0  &@   'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I0P5,75@K+A %\R,2$L6N"K<O
MA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LIDR^SO *1;M(HNSN,P3VH7K.)9
MA@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\./VR./ /,+Q=Z*E%9"E*%1KD
M3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,
M<'AT_@%02P,$%     @ !$A15V60>9(9 0  SP,  !,   !;0V]N=&5N=%]4
M>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !8T\:J_Z39UK2VS-.
MVDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB'2)XKK0A.4G\FK8B
M2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G 8ED\C<+,:DH9HS5*
M$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM 2D9#L9&)7J5CE>BM0#I:
MP'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>,(S/N]G\P68*R,I-"A$Y
ML01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]#&DWY(%B6.;/^'O&%_\;
MSO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    "  $2%%7!T%-8H$   "Q
M    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0
M   (  1(45>EU^]R[0   "L"   1              "  :\   !D;V-0<F]P
M<R]C;W)E+GAM;%!+ 0(4 Q0    (  1(45>97)PC$ 8  )PG   3
M      "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ !$A1
M5]N30AA.!   I!   !@              ("!# @  'AL+W=O<FMS:&5E=',O
M<VAE970Q+GAM;%!+ 0(4 Q0    (  1(45>?H!OPL0(  .(,   -
M      "  9 ,  !X;"]S='EL97,N>&UL4$L! A0#%     @ !$A15Y>*NQS
M    $P(   L              ( !; \  %]R96QS+RYR96QS4$L! A0#%
M  @ !$A15SJJHN=  0  / (   \              ( !51   'AL+W=O<FMB
M;V]K+GAM;%!+ 0(4 Q0    (  1(45<D'INBK0   /@!   :
M  "  <(1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M  1(45=ED'F2&0$  ,\#   3              "  :<2  !;0V]N=&5N=%]4
?>7!E<UTN>&UL4$L%!@     )  D /@(  /$3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="mbrx20231016_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mbrx.com/20231017/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>mbrx-20231017.xsd</File>
    <File>mbrx-20231017_def.xml</File>
    <File>mbrx-20231017_lab.xml</File>
    <File>mbrx-20231017_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="mbrx20231016_8k.htm">mbrx20231016_8k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>mbrx20231016_8kimg001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "mbrx20231016_8k.htm": {
   "nsprefix": "mbrx",
   "nsuri": "http://www.mbrx.com/20231017",
   "dts": {
    "schema": {
     "local": [
      "mbrx-20231017.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "mbrx-20231017_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "mbrx-20231017_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mbrx-20231017_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "mbrx20231016_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 26,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.mbrx.com/20231017/role/statement-document-and-entity-information",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "d20238K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mbrx20231016_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d20238K",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mbrx20231016_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity, Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document, Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.mbrx.com/20231017/role/statement-document-and-entity-information"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001437749-23-028325-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-23-028325-xbrl.zip
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MHNQ)]2*>?%FVIJ2<!#S$,5K;'FTZUS=&0G%;I/P#?[#Q46XL?]A^\S66V^R
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M;T9<I:E 7/AW'RZ/X^ZK/IYL"9H;>@Q?(1]B!;(V&SN^SD<9=E0SO;KUM8A
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M3/='_P902P$"% ,4    "  $2%%7# ;Z78P2  !\:0  #0
M@ $     97A?-3@Q-C,V+FAT;5!+ 0(4 Q0    (  1(45<DPF9#: ,  ' -
M   1              "  ;<2  !M8G)X+3(P,C,Q,#$W+GAS9%!+ 0(4 Q0
M   (  1(45=KX\VJV 0  .<L   5              "  4X6  !M8G)X+3(P
M,C,Q,#$W7V1E9BYX;6Q02P$"% ,4    "  $2%%7K,Y-5O<%  !%/   %0
M            @ %9&P  ;6)R>"TR,#(S,3 Q-U]L86(N>&UL4$L! A0#%
M  @ !$A15Y,RCGMU!   ?RT  !4              ( !@R$  &UB<G@M,C R
M,S$P,3=?<')E+GAM;%!+ 0(4 Q0    (  1(45>X;'SBD@\  &IK   3
M          "  2LF  !M8G)X,C R,S$P,39?.&LN:'1M4$L! A0#%     @
M!$A15Y1TQ?;X"P   PT  !D              ( ![C4  &UB<G@R,#(S,3 Q
D-E\X:VEM9S P,2YJ<&=02P4&      < !P#+ 0  '4(

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
